|
COX4I1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.301400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.296400E-01 |
| Normal-vs-Stage2 |
5.298100E-02 |
| Normal-vs-Stage3 |
5.854400E-01 |
| Normal-vs-Stage4 |
2.437700E-02 |
| Stage1-vs-Stage2 |
8.681200E-03 |
| Stage1-vs-Stage3 |
8.000400E-01 |
| Stage1-vs-Stage4 |
1.084500E-02 |
| Stage2-vs-Stage3 |
6.516300E-03 |
| Stage2-vs-Stage4 |
1.400410E-04 |
| Stage3-vs-Stage4 |
4.165700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.134000E-01 |
| Normal-vs-AfricanAmerican |
2.177800E-01 |
| Normal-vs-Asian |
4.307800E-01 |
| Caucasian-vs-AfricanAmerican |
5.038000E-01 |
| Caucasian-vs-Asian |
9.986400E-01 |
| AfricanAmerican-vs-Asian |
5.369400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.684400E-01 |
| Normal-vs-Female |
5.053800E-01 |
| Male-vs-Female |
1.576820E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.765400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.079400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.080000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.296800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.389400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.459000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.939800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.868400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.813000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.619400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.486030E-01 |
| Classical-VS-Follicular |
1.91500038049242E-10 |
| Classical-VS-Other |
3.229000E-01 |
| Classical-VS-Normal |
2.961800E-02 |
| Tall-VS-Follicular |
2.39609998509138E-10 |
| Tall-VS-Other |
5.156300E-02 |
| Tall-VS-Normal |
7.779200E-03 |
| Follicular-VS-Other |
2.541600E-02 |
| Follicular-VS-Normal |
3.005500E-04 |
| Other-VS-Normal |
9.543600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.583800E-01 |
| Normal-vs-N1 |
1.740760E-01 |
| N0-vs-N1 |
7.681400E-03 |
|
|
